Intravitreal bevacizumab in aggressive posterior r...[Indian J Ophthalmol. 2007 Jul-Aug]

SearchDatabase nameforSearch term

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

1: Indian J Ophthalmol. 2007 Jul-Aug;55(4):319; author reply 320. Links

Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity.

PMID: 17595491 [PubMed - indexed for MEDLINE]

Intravitreal bevacizumab (Avastin) for post-laser photocoagulation anterior segment ischemia in aggressive posterior retinopathy of prematurity.
Indian J Ophthalmol. 2007 Jul-Aug; 55(4):317; author reply 317-8.

[Indian J Ophthalmol. 2007]
Off-label use of bevacizumab in retinopathy of prematurity.
Retina. 2009 Feb; 29(2):284; author reply 284-5.

[Retina. 2009]
Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity.
Ophthalmic Surg Lasers Imaging. 2007 May-Jun; 38(3):233-7.

[Ophthalmic Surg Lasers Imaging. 2007]
ReviewThe treatment of branch retinal vein occlusion with bevacizumab.
Curr Opin Ophthalmol. 2008 May; 19(3):234-8.

[Curr Opin Ophthalmol. 2008]
ReviewSurgical management of retinopathy of prematurity.
Curr Opin Ophthalmol. 2008 Sep; 19(5):384-90.

[Curr Opin Ophthalmol. 2008]
» See reviews... | » See all...

Bevacizumab Injection (Avastin® )
Bevacizumab is used with chemotherapy to treat cancer of the colon (large intestine) or rectum that has spread to other parts of the body. Bevacizumab is also used with chemotherapy to treat certain types of lung cancer....
Source: AHFS Consumer Medication Information

Your browsing activity is empty.

Activity recording is turned off.

Display Show